FRANKLIN RESOURCES INC

Position in GRFS — Grifols SA

CIK 38777 San Mateo, CA

Position in GRFS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$157,279

-$42,277 QoQ

Shares Held

19,611

-8.1% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FRANKLIN RESOURCES INC holds $19,026,917,368 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,471,778	$4,113,007,243
2	AZN	Astrazeneca PLC	17,792,161	$3,508,969,981
3	ABBV	AbbVie Inc.	14,552,069	$3,164,929,479
4	JNJ	Johnson & Johnson	10,474,706	$2,560,437,127
5	MRK	Merck & Co., Inc.	16,267,205	$1,956,782,081
6	PFE	Pfizer Inc	28,341,834	$795,838,692
7	NVO	Novo Nordisk A S	16,083,479	$591,067,849
8	AMGN	Amgen Inc	1,500,535	$527,963,233

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$157,279	19,611	-8.1%	Shares	Defined	2026-05-13
2025-12-31	$199,556	21,343	+10.9%	Shares	Defined	2026-02-11
2025-09-30	$191,620	19,239	+29.9%	Shares	Defined	2025-11-13
2023-12-31	$171,226	14,812	+2.2%	Shares	Defined	2024-02-09
2023-09-30	$132,465	14,493	+1.7%	Shares	Defined	2023-11-13
2023-06-30	$130,502	14,247	-19.2%	Shares	Defined	2023-08-11
2023-03-31	$129,976	17,636	-9.0%	Shares	Defined	2023-05-12
2022-12-31	$164,653	19,371	-19.5%	Shares	Defined	2023-02-10
2022-06-30	$285,820	24,059	+74.1%	Shares	Defined	2022-08-11
2022-03-31	$161,440	13,822	+1.3%	Shares	Defined	2022-05-13
2021-12-31	$153,210	13,643	—	Shares	Defined	2022-02-11
No filing history on record for this holder in this stock.